Guajak-Test (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Guajak-Test" in German language version.

refsWebsite

Global rank German rank

6doi.org

2^nd place

3^rd place

5nih.gov

4^th place

7^th place

1gelbe-liste.de

low place

2,430^th place

1elsevierhealth.com

low place

1g-ba.de

low place

1,618^th place

1web.archive.org

1^st place

doi.org

David H. Greegor, Jr.: Occult blood testing for detection of asymptomatic colon cancer. In: Cancer. Band 28, Nr. 1, 1971, S. 131–134, doi:10.1002/1097-0142(197107)28:1<131::AID-CNCR2820280125>3.0.CO;2-I, PMID 5110619.
R. M. McLoughlin, C. A. O’Morain: Colorectal cancer screening. In: World journal of gastroenterology. Band 12, Nummer 42, November 2006, S. 6747–6750; doi:10.3748/wjg.v12.i42.6747. PMID 17106920, PMC 4087426 (freier Volltext) (Review).
James E. Allison, Irene S. Tekawa, Laura J. Ransom, Alyn L. Adrain: A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening. In: The New England Journal of Medicine. Band 334, Nr. 3, 1996, S. 155–159, doi:10.1056/NEJM199601183340304, PMID 8531970.
David A. Lieberman, David G. Weiss u. a. (Veterans Affairs Cooperative Study Group 380): One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon. In: The New England Journal of Medicine. Band 345, Nr. 8, 2001, S. 555–560, doi:10.1056/NEJMoa010328, PMID 11529208.
Sidney J. Winawer u. a.: Colorectal cancer screening. Clinical guidelines and rationale. In: Gastroenterology. Band 112, Nr. 2, 1997, S. 594–642, doi:10.1053/gast.1997.v112.agast970594, PMID 9322544 (elsevierhealth.com [PDF]).
A. Graser et al.: Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. In: Gut. Band 58, Nr. 2, 2009, S. 241–248; doi:10.1136/gut.2008.156448

elsevierhealth.com

download.journals.elsevierhealth.com

Sidney J. Winawer u. a.: Colorectal cancer screening. Clinical guidelines and rationale. In: Gastroenterology. Band 112, Nr. 2, 1997, S. 594–642, doi:10.1053/gast.1997.v112.agast970594, PMID 9322544 (elsevierhealth.com [PDF]).

g-ba.de

Darmkrebs-Screening wird auf neuem Testverfahren basieren. G-BA, Pressemitteilung, 21. April 2016, abgerufen am 26. April 2016.

gelbe-liste.de

Hemoccult^® SENSA^® Test – Beckman Coulter GmbH. Präparateinformationen. In: Gelbe Liste Pharmindex. 15. Februar 2014, abgerufen am 1. März 2014.

nih.gov

ncbi.nlm.nih.gov

David H. Greegor, Jr.: Occult blood testing for detection of asymptomatic colon cancer. In: Cancer. Band 28, Nr. 1, 1971, S. 131–134, doi:10.1002/1097-0142(197107)28:1<131::AID-CNCR2820280125>3.0.CO;2-I, PMID 5110619.
R. M. McLoughlin, C. A. O’Morain: Colorectal cancer screening. In: World journal of gastroenterology. Band 12, Nummer 42, November 2006, S. 6747–6750; doi:10.3748/wjg.v12.i42.6747. PMID 17106920, PMC 4087426 (freier Volltext) (Review).
James E. Allison, Irene S. Tekawa, Laura J. Ransom, Alyn L. Adrain: A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening. In: The New England Journal of Medicine. Band 334, Nr. 3, 1996, S. 155–159, doi:10.1056/NEJM199601183340304, PMID 8531970.
David A. Lieberman, David G. Weiss u. a. (Veterans Affairs Cooperative Study Group 380): One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon. In: The New England Journal of Medicine. Band 345, Nr. 8, 2001, S. 555–560, doi:10.1056/NEJMoa010328, PMID 11529208.
Sidney J. Winawer u. a.: Colorectal cancer screening. Clinical guidelines and rationale. In: Gastroenterology. Band 112, Nr. 2, 1997, S. 594–642, doi:10.1053/gast.1997.v112.agast970594, PMID 9322544 (elsevierhealth.com [PDF]).

web.archive.org

Nationaler Krebsplan. (Memento vom 6. März 2016 im Internet Archive; PDF; 270 kB) Handlungsfeld 1: Ziele-Papier 2 b. Weiterentwicklung der Darmkrebsfrüherkennung (u. a. Entwicklung eines organisierten Darmkrebs-Screenings)